These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 18675061)

  • 21. Graft histology characteristics in long-term survivors of pediatric liver transplantation.
    Ekong UD; Melin-Aldana H; Seshadri R; Lokar J; Harris D; Whitington PF; Alonso EM
    Liver Transpl; 2008 Nov; 14(11):1582-7. PubMed ID: 18975292
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Excision and reconstruction of anomalous portal venous branching in adult-to-adult right lobe living donor liver transplantation].
    Xu MQ; Yan LN; Li B; Zeng Y; Wen TF; Zhao JC; Wang WT; Yang JY; Ma YK; Cheng ZY; Zhang ZW
    Zhonghua Wai Ke Za Zhi; 2008 Feb; 46(3):170-2. PubMed ID: 18683709
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunohistochemical staining of liver grafts with a monoclonal antibody against HCV-Envelope 2 for recurrent hepatitis C after living donor liver transplantation.
    Sadamori H; Yagi T; Iwagaki H; Matsuda H; Shinoura S; Umeda Y; Ohara N; Yanai H; Ogino T; Tanaka N
    J Gastroenterol Hepatol; 2009 Apr; 24(4):574-80. PubMed ID: 19368635
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is recurrent hepatitis C worse with living donors?
    Kuo A; Terrault NA
    Curr Opin Organ Transplant; 2009 Jun; 14(3):240-4. PubMed ID: 19395968
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Hepatic arterial reconstruction and complications management in adult-to-adult living donor liver transplantation].
    Zhao JC; Yan LN; Li B; Ma YK; Zeng Y; Wen TF; Wang WT; Yang JY; Xu MQ; Chen ZY
    Zhonghua Wai Ke Za Zhi; 2008 Feb; 46(3):166-9. PubMed ID: 18683708
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevent small-for-size syndrome using dual grafts in living donor liver transplantation.
    Chen Z; Yan L; Li B; Zeng Y; Wen T; Zhao J; Wang W; Xu M; Yang J
    J Surg Res; 2009 Aug; 155(2):261-7. PubMed ID: 19481224
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Liver biopsy findings from healthy potential living liver donors: reasons for disqualification, silent diseases and correlation with liver injury tests.
    Minervini MI; Ruppert K; Fontes P; Volpes R; Vizzini G; de Vera ME; Gruttadauria S; Miraglia R; Pipitone L; Marsh JW; Marcos A; Gridelli B; Demetris AJ
    J Hepatol; 2009 Mar; 50(3):501-10. PubMed ID: 19155086
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Body mass index evaluating donor hepatic steatosis in living donor liver transplantation.
    Peng CJ; Yuan D; Li B; Wei YG; Yan LN; Wen TF; Zhao JC; Yang JY; Wang WT; Xu MQ
    Transplant Proc; 2009 Nov; 41(9):3556-9. PubMed ID: 19917343
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Living donor liver transplantation: the decision experience].
    Weng LC; Huang HL; Chang CL; Kuo MC
    Hu Li Za Zhi; 2009 Aug; 56(4):89-93. PubMed ID: 19634104
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Living-related donor liver transplantation for children with fulminant hepatic failure in Israel.
    Shouval DS; Mor E; Avitzur Y; Shamir R; Bar-Nathan N; Steinberg R; Schoenfeld T; Ben-Ari Z; Shapiro R
    J Pediatr Gastroenterol Nutr; 2009 Apr; 48(4):451-5. PubMed ID: 19322055
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Allograft steatohepatitis in progressive familial intrahepatic cholestasis type 1 after living donor liver transplantation.
    Miyagawa-Hayashino A; Egawa H; Yorifuji T; Hasegawa M; Haga H; Tsuruyama T; Wen MC; Sumazaki R; Manabe T; Uemoto S
    Liver Transpl; 2009 Jun; 15(6):610-8. PubMed ID: 19479804
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Requirement of protocol biopsy before and after complete cessation of immunosuppression after liver transplantation.
    Yoshitomi M; Koshiba T; Haga H; Li Y; Zhao X; Cheng D; Miyagawa A; Sakashita H; Tsuruyama T; Ohe H; Ueda M; Okamoto S; Egawa H; Wood K; Sakaguchi S; Manabe T; Tanaka K; Uemoto S
    Transplantation; 2009 Feb; 87(4):606-14. PubMed ID: 19307800
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Living donor liver transplantation in pediatric patients with acute liver failure: safe and effective alternative.
    Uribe M; González G; Alba A; Godoy J; Ferrario M; Hunter B; Iñiguez R; Cavallieri S; Díaz V; Macho L; Ferrón S; Buckel E
    Transplant Proc; 2008 Nov; 40(9):3253-5. PubMed ID: 19010246
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Variant techniques for liver transplantation in pediatric programs.
    Burgos L; Hernández F; Barrena S; Andres AM; Encinas JL; Leal N; Gamez M; Murcia J; Jara P; Lopez-Santamaria M; Tovar JA
    Eur J Pediatr Surg; 2008 Dec; 18(6):372-4. PubMed ID: 19039737
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discontinuation of living donor liver transplantation for PSC due to histological abnormalities in intraoperative donor liver biopsy.
    Hasegawa Y; Kawachi S; Shimazu M; Hoshino K; Tanabe M; Fuchimoto Y; Obara H; Shinoda M; Shimizu H; Yamada Y; Akatsu T; Irie R; Sakamoto M; Morikawa Y; Kitajima M
    Am J Transplant; 2007 Sep; 7(9):2204-7. PubMed ID: 17614979
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mild hepatic macrovesicular steatosis may be a risk factor for hyperbilirubinaemia in living liver donors following right hepatectomy.
    Nagai S; Fujimoto Y; Kamei H; Nakamura T; Kiuchi T
    Br J Surg; 2009 Apr; 96(4):437-44. PubMed ID: 19283738
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recurrent familial hypobetalipoproteinemia-induced nonalcoholic fatty liver disease after living donor liver transplantation.
    Harada N; Soejima Y; Taketomi A; Yoshizumi T; Uchiyama H; Ikegami T; Saibara T; Nishizaki T; Maehara Y
    Liver Transpl; 2009 Jul; 15(7):806-9. PubMed ID: 19562718
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Living donor liver transplantation in India.
    Soin AS; Kakodkar R
    Trop Gastroenterol; 2007; 28(3):96-8. PubMed ID: 18383995
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Percutaneous transhepatic treatment of hepaticojejunal anastomotic biliary strictures after living donor liver transplantation.
    Ko GY; Sung KB; Yoon HK; Kim KR; Gwon DI; Lee SG
    Liver Transpl; 2008 Sep; 14(9):1323-32. PubMed ID: 18756470
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Technique and outcome of autologous portal Y-graft interposition for anomalous right portal veins in living donor liver transplantation.
    Hwang S; Lee SG; Ahn CS; Kim KH; Moon DB; Ha TY; Song GW; Jung DH; Ryu JH; Ko KH; Choi NK; Kim KW
    Liver Transpl; 2009 Apr; 15(4):427-34. PubMed ID: 19326410
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.